The 340B program just crossed a threshold that would have been unimaginable when it launched: $100 billion in discounted drug purchases in a single year according to 2025 340B purchase data released by Health Resources and Services Administration (HRSA). Ten years ago, 340B covered entities purchased $12 billion in covered outpatient drugs in a year. Today, that is roughly what they purchase every six weeks. The growth is not evenly distributed. Nearly 9 in 10 dollars spent i

Quorum Health, a private equity-backed chain of 11 hospitals, recently announced it is converting to a nonprofit business model. The company framed the move as a commitment to "mission-driven" care for rural communities, but a closer look tells a different story. Two Private Equity firms – Davidson Kempner Capital Management and GoldenTree Asset Management – established control of Quorum after its bankruptcy. Now, GoldenTree owns the majority stake. Quorum once operated near

Minnesota hospitals participating in the federal 340B drug discount program are supposed to turn deep drug discounts into tangible relief for patients. But the state’s own data shows a widening gap between what hospitals gain and what patients experience. According to Minnesota’s most recent 340B report, participating hospitals collected $1.34 billion in net 340B revenue in 2024 – receiving $3.04 billion in discounts for medications they purchased for just $1.53 billion. Yet

April 17, 2026 Health Resources and Services Administration Rebate Model in the 340B Program HHS Docket No. HRSA-2026-03042 We, the undersigned organizations, representing the interests of workers, faith leaders, healthcare providers, and patient advocates, offer these comments in response to Health Resources and Service Administration’s (HRSA) consideration of a rebate model under the 340B program, consistent with our mission to restore patient-centered care. Evaluating a r

MILWAUKEE ( March 26, 2026) -- Hospitals in Minnesota participating in the federal 340B Drug Pricing Program are directing tens of millions of dollars from the program into financial investments rather than expanding care for vulnerable patients, according to a new analysis by Dr. Lisa Grabert, a health policy researcher at Marquette University. On average, Minnesota hospitals in the program invested $52.2 million in stocks and bonds, more than three times the $14.2 millio

MILWAUKEE (March 19, 2026) -- New York hospitals participating in the federal 340B Drug Discount Program are generating substantially higher revenues and directing large sums into Wall Street investments rather than expanding care for vulnerable patients, according to a new analysis by Dr. Lisa Grabert, a health policy researcher at Marquette University and former senior House Ways and Means Committee aide. The study finds that New York's 340B hospitals invested 42% more reve

MILWAUKEE (March 12, 2026) -- Illinois hospitals participating in the federal 340B Drug Pricing Program are generating significantly higher revenues and investing far more money in stocks and bonds than other hospitals, according to an analysis published today by health policy researcher Dr. Lisa Grabert. The study finds that Illinois hospitals participating in the program reported 41% higher patient revenue than non-340B hospitals and invested 119% more revenue in financ

Irene Gebrael was an Arabic interpreter at Montefiore when, she said, she had an idea: If the hospital recruited international patients, it could serve a broader population – and make a lot of money. “The hospital is always happy about the international rates,” Ms. Gebrael said in an interview. “Trust me.” In 2013, she said, she persuaded hospital executives to start an international office. It was good timing for the transplant program. For decades, hospitals that gave mo

Nearly one third of working-age adults in the U.S. are in medical debt, according to the most recent data from The Commonwealth Fund . Of those adults with medical debt, 40% have had to cut back on basic necessities to pay back their debt. Considering this rising issue, ProPublica reported on the medical debt collection practices of non-profit hospitals and clinics across the country. One community health center in Virginia, which participates in the 340B drug discount pro

WASHINGTON, D.C. (Jan. 29, 2026) -- Virginia's 340B hospitals invested nearly five times more in stocks and bonds than non-340B hospitals, netting millions off the federal drug discount program, according to a new analysis by Dr. Lisa Grabert, a health policy researcher at Marquette University and former senior House Ways and Means Committee aide. "The 340B program isn't working for the Virginia families it was designed to help," Grabert said. "Too many of the state's disprop